75F40122C00133
Definitive Contract
Overview
Government Description
LEACHABLE ENDS RESEARCH CTP-22-C-107229
Awarding / Funding Agency
PSC
Place of Performance
Silver Spring, MD 20903 United States
Pricing
Fixed Price
Set Aside
None
Extent Competed
Not Competed Under Simplified Acquisition Procedures
Est. Average FTE
3
Related Opportunity
FDA22RFP1246427
Eurofins Biopharma Product Testing Columbia was awarded
Definitive Contract 75F40122C00133 (75F401-22-C-00133)
for Leachable Ends Research Ctp-22-C-107229
worth up to $664,052
by the FDA Office of Acquisition and Grant Services
in September 2022.
The contract
has a duration of 1 year 2 months and
was awarded
full & open
with
NAICS 541715 and
PSC AJ12
via simplified acquisition acquisition procedures with 1 bid received.
Status
(Closed)
Last Modified 4/18/25
Period of Performance
9/15/22
Start Date
11/29/23
Current End Date
11/29/23
Potential End Date
Obligations
$664.1K
Total Obligated
$664.1K
Current Award
$664.1K
Potential Award
Award Hierarchy
Definitive Contract
75F40122C00133
Subcontracts
Activity Timeline
People
Suggested agency contacts for 75F40122C00133
Competition
Number of Bidders
1
Solicitation Procedures
Simplified Acquisition
Other Than Full and Open Competition
SAP Non-Competition
Evaluated Preference
None
Commercial Item Acquisition
Commercial Item
Simplified Procedures for Commercial Items
Yes
Other Categorizations
Subcontracting Plan
Plan Not Included (No Subcontracting Possibilities)
Cost Accounting Standards
Exempt
Business Size Determination
Large Business
Awardee UEI
TA25MK73FKW5
Awardee CAGE
8DH61
Agency Detail
Awarding Office
75F401 FDA OFFICE OF ACQ GRANT SVCS
Funding Office
75F401
Created By
hhsljackson
Last Modified By
hhskimberlymccarthy
Approved By
hhseeam
Legislative
Legislative Mandates
None Applicable
Performance District
MD-08
Senators
Benjamin Cardin
Chris Van Hollen
Chris Van Hollen
Representative
Jamie Raskin
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
Salaries and Expenses, Food and Drug Administration, Health and Human Services (075-0600) | Consumer and occupational health and safety | Advisory and assistance services (25.1) | $664,052 | 100% |
Modified: 4/18/25